Sarepta Therapeutics Inc is categorized under Research and Development Laboratories in Corvallis, OR .
Sarepta Therapeutics Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Alan Timmins, Administrator at the company’s branch by writing to 4575 Sw Research Way # 200, Corvallis, Oregon OR 97333 or by phoning (541) 753-3635. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sarepta Therapeutics Inc |
| Contact Person: | Alan Timmins, Administrator |
| Address: | 4575 Sw Research Way # 200, Corvallis, Oregon 97333 |
| Phone Number: | (541) 753-3635 |
| Website Address: | sareptatherapeutics.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 5417110 |
| Share This Business: |
Sarepta Therapeutics Inc was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Alan Timmins, Administrator for inquiries that concern Sarepta Therapeutics Inc by calling the company number (541) 753-3635, as your correspondence is most welcome. Additionally, the physical location of the branch of Sarepta Therapeutics Inc can be found at the coordinates 44.55175,-123.30287 as well as the street address 4575 Sw Research Way # 200 in Corvallis, Oregon 97333.
For its online presence, you may visit Sarepta Therapeutics Inc’s website at sareptatherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.